Ralph Alderson has extensive work experience in the biotechnology industry. Ralph started their career in 1989 as a Scientist at Regeneron and then worked at Human Genome Sciences as a Senior Scientist from 1995 to 2005. After that, they joined Genencor International as a Senior Scientist in 2005. In the same year, they also started working at Cambridge Antibody Technology/AstraZeneca as a Senior Scientist until 2007. Ralph then became an Independent Biotechnology Consultant from 2007 to 2009 before joining MacroGenics as a Director In Vivo Pharmacology in 2009, where they are currently employed.
Ralph Alderson's education history includes attending the University of Connecticut. However, no specific information is available regarding the degree name or field of study, as well as the exact years of attendance.
May, 2009 - present
Senior Director, In Vivo Pharmacology at Catamaran Bio
Director, In Vivo Pharmacology at Crinetics Pharmaceuticals
Director, In Vivo Pharmacology at Vesigen Therapeutics
Sr. Director In Vivo Pharmacology at Skyhawk Therapeutics
Senior Director In Vivo Pharmacology at ethris